Oramed Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021
Period Ending	Feb '26 Feb 6, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Aug '21 Aug 31, 2021
Market Capitalization	136	98	93	471	544	640
Market Cap Growth	46.41%	4.69%	-80.20%	-13.48%	-15.00%	479.35%
Enterprise Value	2	-46	-9	311	444	565
Last Close Price	3.41	2.26	2.15	11.21	13.31	18.35
PE Ratio	3.32	-	16.87	-	-	-
PS Ratio	70.49	-	69.54	174.08	200.54	236.73
PB Ratio	0.69	0.67	0.57	3.11	3.26	5.49
P/TBV Ratio	0.67	0.67	0.57	3.10	3.27	5.53
EV/Sales Ratio	0.95	-	-	115.15	163.83	208.87
Debt / Equity Ratio	0.00	0.00	0.32	0.01	0.00	0.01
Asset Turnover	0.01	-	0.01	0.02	-	0.03
Quick Ratio	22.08	24.97	3.05	27.10	19.85	14.10
Current Ratio	22.25	25.19	3.06	27.34	20.08	14.27
Return on Equity (ROE)	24.48%	-12.39%	3.24%	-23.77%	-	-30.78%
Return on Assets (ROA)	-4.22%	-4.25%	-5.16%	-14.95%	-	-17.54%
Return on Capital Employed (ROCE)	-6.10%	-8.50%	-9.40%	-26.00%	-21.70%	-20.00%
Earnings Yield	32.31%	-19.54%	5.93%	-7.77%	-6.44%	-3.48%
FCF Yield	-7.82%	-8.64%	-11.32%	-6.04%	-6.14%	-3.37%
Buyback Yield / Dilution	-3.29%	-0.65%	-4.02%	-5.08%	-30.36%	-16.71%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q